Technical Analysis for JAGX - Jaguar Animal Health, Inc.

Grade Last Price % Change Price Change
grade F 0.465 192.64% 0.31
JAGX closed up 192.64 percent on Monday, March 18, 2019, on 30.01 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical JAGX trend table...

Date Alert Name Type % Chg
Mar 18 Crossed Above 20 DMA Bullish 0.00%
Mar 18 Crossed Above 50 DMA Bullish 0.00%
Mar 18 MACD Bullish Centerline Cross Bullish 0.00%
Mar 18 New Uptrend Bullish 0.00%
Mar 18 Expansion Breakout Bullish Swing Setup 0.00%
Mar 18 Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Mar 18 Pocket Pivot Bullish Swing Setup 0.00%
Mar 18 Volume Surge Other 0.00%
Mar 18 Wide Range Bar Range Expansion 0.00%
Mar 18 Parabolic Rise Strength 0.00%

Older signals for JAGX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar Animal Health, Inc. is a subsidiary of Napo Pharmaceuticals, Inc.
Medicine Medical Specialties Gastroenterology Diarrhea Gastrointestinal Tract Salix Pharmaceuticals Gastrointestinal Products
Is JAGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.525
52 Week Low 0.115
Average Volume 2,212,241
200-Day Moving Average 0.6984
50-Day Moving Average 0.2394
20-Day Moving Average 0.1996
10-Day Moving Average 0.1932
Average True Range 0.0455
ADX 34.98
+DI 62.0527
-DI 10.6246
Chandelier Exit (Long, 3 ATRs ) 0.3833
Chandelier Exit (Short, 3 ATRs ) 0.2765
Upper Bollinger Band 0.334
Lower Bollinger Band 0.0652
Percent B (%b) 1.49
BandWidth 134.669339
MACD Line 0.002
MACD Signal Line -0.0184
MACD Histogram 0.0204
Fundamentals Value
Market Cap 50.31 Million
Num Shares 108 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -2.98
Price-to-Sales 11.19
Price-to-Book 0.00
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.00
Resistance 3 (R3) 0.96 0.74 0.91
Resistance 2 (R2) 0.74 0.60 0.76 0.88
Resistance 1 (R1) 0.60 0.52 0.67 0.64 0.85
Pivot Point 0.38 0.38 0.42 0.40 0.38
Support 1 (S1) 0.25 0.25 0.31 0.29 0.08
Support 2 (S2) 0.03 0.16 0.05 0.05
Support 3 (S3) -0.11 0.03 0.02
Support 4 (S4) -0.07